LEP and type 2 diabetes mellitus: Garvey W.T. et al. evaluated the correlation between the change in leptin and adiponectin levels measured in a randomly selected subgroup of patients with type 2 diabetes receiving canagliflozin 300 mg (n = 100) or glimepiride (n = 100).